Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y017514 | SYR / RA |
RN administered the Varivax vaccine and ProQuad vaccine on the same day. RN thought that she was administering MMR instead of ProQuad, but administered ProQuad (MMRV) and Varivax together. RN spoke to MD after the event around 11:15. RN notified the pt and the pt guardian that the pt received 2 doses of Varicella. Pt was monitored for 20 min after the event. No adverse outcomes were noted. RN gave pt strict return to clinic / ED protocol if pt develops a rash, fever > 101 F, difficulty breathing, facial swelling, or other concerning symptoms.
No illnesses reported.
No long-standing health conditions reported.
No medications reported.
No allergies reported.
No relevant medical tests or laboratory results.